α-Cyclodextrin
Molecular FormulaC36H60O30
- 30 of 30 defined stereocentres
(1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31R,32R,33R,34R,35R,36R,37R,38R,39R,40R,41R,42R)-5,10,15,20,25,30-Hexakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29-dodecaoxahe ptacyclo[26.2.2.2~3,6~.2~8,11~.2~13,16~.2~18,21~.2~23,26~]dotetracontane-31,32,33,34,35,36,37,38,39,40,41,42-dodecol (non-preferred name)
C([C@@H]1[C@@H]2[C@@H]([C@H]([C@H](O1)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5O)O)O[C@@H]6[C@H](O[C@@H]([C@@H]([C@H]6O)O)O[C@@H]7[C@H](O[C@H](O2)[C@@H]([C@H]7O)O)CO)CO)CO)CO)CO)O)O)O
InChI=1S/C36H60O30/c37-1-7-25-13(43)19(49)31(55-7)62-26-8(2-38)57-33(21(51)15(26)45)64-28-10(4-40)59-35(23(53)17(28)47)66-30-12(6-42)60-36(24(54)18(30)48)65-29-11(5-41)58-34(22(52)16(29)46)63-27-9(3-39)56-32(61-25)20(50)14(27)44/h7-54H,1-6H2/t7-,8-,9-,10-,11-,12-,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23-,24-,25-,26-,27-,28-,29-,30-,31-,32-,33-,34-,35-,36-/m1/s1
HFHDHCJBZVLPGP-RWMJIURBSA-N
(1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31R,32R,33R,34R,35R,36R,37R,38R,39R,40R,41R,42R)-5,10,15,20,25,30-Hexakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29-dodecaoxahe ;ptacyclo[26.2.2.23,6.28,11.213,16.218,21.223,26]dotetracontan-31,32,33,34,35,36,37,38,39,40,41,42-dodecol [German] [ACD/IUPAC Name]
(1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31R,32R,33R,34R,35R,36R,37R,38R,39R,40R,41R,42R)-5,10,15,20,25,30-Hexakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29-dodecaoxahe ;ptacyclo[26.2.2.23,6.28,11.213,16.218,21.223,26]dotetracontane-31,32,33,34,35,36,37,38,39,40,41,42-dodecol [ACD/IUPAC Name]
(1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31R,32R,33R,34R,35R,36R,37R,38R,39R,40R,41R,42R)-5,10,15,20,25,30-Hexakis(hydroxyméthyl)-2,4,7,9,12,14,17,19,22,24,27,29-dodécaoxahe ;ptacyclo[26.2.2.23,6.28,11.213,16.218,21.223,26]dotétracontane-31,32,33,34,35,36,37,38,39,40,41,42-dodécol [French] [ACD/IUPAC Name]
(1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31R,32R,33R,34R,35R,36R,37R,38R,39R,40R,41R,42R)-5,10,15,20,25,30-Hexakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29-dodecaoxaheptacyclo[26.2.2.23,6.28,11.213,16.218,21.223,26]dotetracontan-31,32,33,34,35,36,37,38,39,40,41,42-dodecol
(1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31R,32R,33R,34R,35R,36R,37R,38R,39R,40R,41R,42R)-5,10,15,20,25,30-Hexakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29-dodecaoxaheptacyclo[26.2.2.23,6.28,11.213,16.218,21.223,26]dotetracontane-31,32,33,34,35,36,37,38,39,40,41,42-dodecol
(1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31R,32R,33R,34R,35R,36R,37R,38R,39R,40R,41R,42R)-5,10,15,20,25,30-Hexakis(hydroxyméthyl)-2,4,7,9,12,14,17,19,22,24,27,29-dodécaoxaheptacyclo[26.2.2.23,6.28,11.213,16.218,21.223,26]dotétracontane-31,32,33,34,35,36,37,38,39,40,41,42-dodécol [French]
(1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31R,32R,33R,34R,35R,36R,37R,38R,39R,40R,41R,42R)-5,10,15,20,25,30-Hexakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29-dodecaoxaheptacyclo[26.2.2.23,6.28,11.213,16.218,21.223,26]dotetracontane-31,32,33,34,35,36,37,38,39,40,41,42-dodecol (non-preferred name)
(5R,10R,15R,20R,25R,30R,31R,32R,33R,34R,35R,36R,37R,38R,39R,40R,41R,42R)-5,10,15,20,25,30-hexakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29-dodecaoxaheptacyclo[26.2.2.23,6.28,11.213,16.218,21.223,26]dotetracontane-31,32,33,34,35,36,37,38,39,40,41,42-dodecol
10016-20-3 [RN]
233-007-4 [EINECS]
79627 [Beilstein]
a-Cycloamylose
a-Cyclodextrin
a-Dextrin
alfadex [Spanish] [INN]
alfadex [French] [INN]
ALFADEX [INN]
alfadexum [Latin] [INN]
a-Schardinger Dextrin
Cavamax(R) W6
Cavamax(R) W6 Pharma
Celdex A 100
Cyclohexaamylose
cyclomaltohexaose
Dexy Pearl a-100
Ringdex A
Z1LH97KTRM
α Cyclodextrin
α-Cycloamylose
α-Dextrin
α-Schardinger dextrin
β-CD
альфадекс [Russian] [INN]
ألفاداكس [Arabic] [INN]
阿法环糊精 [Chinese] [INN]
(c6,1-4)GLC-(1-4)GLC-(1-4)GLC-(1-4)GLC-(1-4)GLC-(1-4)GLC
??-Cyclodextrin
1678944 [Beilstein]
1678944; 79627
Cyclohexapentylose
Cyclomaltohexose
GU 2292000
UNII-Z1LH97KTRM
α-CD
28705_FLUKA [DBID]
AIDS187883 [DBID]
AIDS-187883 [DBID]
C4642_SIGMA [DBID]
CHEBI:33103 [DBID]
NSC 269470 [DBID]
Experimental Melting Point:
278 °C (Decomposes, Literature) Indofine [024438]
270 °C (Decomposes) Oxford University Chemical Safety Data (No longer updated) More details
274 °C Biosynth C-9100
278 °C (Decomposes, Literature) Indofine [024438] , [024438]
hexagonal plates or blade-shaped needles Oxford University Chemical Safety Data (No longer updated) More details
Stable. Combustbile. Incompatible with strong oxidizing agents. Oxford University Chemical Safety Data (No longer updated) More details
IPR-RAT LD50 1000 mg kg-1, IVN-RAT LD50 788 mg kg-1 Oxford University Chemical Safety Data (No longer updated) More details
Minimize contact. Oxford University Chemical Safety Data (No longer updated) More details
A cycloamylose composed of six <stereo>alpha</stereo>-(1<arrow>right</arrow>4) linked <stereo>D</stereo>-glucopyranose units. ChEBI CHEBI:40585
Boiling Point: 1410.8±60.0 °C at 760 mmHg
Enthalpy of Vaporization: 241.4±6.0 kJ/mol
Molar Refractivity: 202.4±0.3 cm3
#H bond acceptors: 30
#H bond donors: 18
Polar Surface Area: 475 Å2